Overview +

All Sanguine study protocols and their resulting samples, which include all Sanguine at-home and apheresis collection programs, are conducted under an Institutional Review Board (IRB). Sanguine operates under an electronic informed consent process which executes 21 CFR part 11 compliant e-signatures, and Sanguine systems interacting with study participant information are HIPAA-compliant.

Sanguine’s fresh whole blood collection ensures high-quality, viable samples for research and therapeutic applications. Available in custom volumes with flexible anticoagulant options, our fresh whole blood is ideal for immunology, hematology, and biomarker research.

Well-characterized whole blood for Alzheimer’s research supports studies on neurodegeneration, amyloid and tau pathology, and therapeutic development to advance understanding and treatments for cognitive decline.

Infectious disease testing requirements differ globally. If you are ordering from outside the U.S., please reach out at to confirm that we can meet your country’s regulatory and documentation needs.